Skip to content
Rapid VentRapid Vent Calculator

Rocuronium RSI dose for adults: verify the 1 mg/kg estimate and why duration matters

Published 

The rocuronium RSI dose StatPearls gives is 1 mg/kg IV, inside the FDA label’s rapid sequence intubation range of 0.6 to 1.2 mg/kg. The label reports excellent or good intubating conditions in most patients in under 2 minutes at that range. Rapid Vent Calculator multiplies 1 mg/kg by the actual body weight entered. Higher doses last longer: the label’s median clinical duration runs from 31 minutes at 0.6 mg/kg to 67 minutes at 1.2 mg/kg, far longer than the induction agent, which is why the label says its use must be accompanied by adequate anesthesia or sedation. Adult patients only, and the crew’s protocol sets the dose; see the adult RSI medications table with all six doses for the other five drugs.

Rocuronium RSI dose: what each source states
SourceWhat it statesSetting and population
FDA rocuronium labelRapid sequence intubation 0.6 to 1.2 mg/kg, excellent or good intubating conditions in most patients in under 2 minutes; routine intubation recommended initial dose 0.6 mg/kg; obese patients’ initial dose based on actual body weightAdjunct to general anesthesia; appropriately premedicated and adequately anesthetized patients
StatPearls NBK4592761 mg/kg for intubationRapid sequence intubation; no weight descriptor
Erstad and Barletta, 2021Ideal or adjusted (or lean) body weight suggested for non-depolarizing paralytics in obesity, class-levelNarrative review, patients with obesity; perioperative evidence base
McDowell et al., 2024Ideal-weight dosing did not show non-inferiority to total-weight dosing for excellent intubating conditions; paralysis 43 vs 71 minutesProspective observational, obese adults, ED RSI
April et al., 2026Doses above 1.2 mg/kg associated with higher first-attempt success overall and in ICU intubations, not in ED intubationsSecondary analysis of two multicenter trials, critically ill adults, 9 EDs and 24 ICUs
Szesnat et al., 2026Doses above 1.2 mg/kg associated with higher first-attempt success (100% vs 89.5%) and fewer mean attempts; no difference in other secondary outcomes or subgroupsSingle-center retrospective, adults, ED and ICU, video laryngoscopy

Figures are what each source reports, not a dosing instruction. The label’s figures come from anesthesia with premedication. The two 2026 studies are observational associations. Your protocol sets the dose.

Where the 1 mg/kg rocuronium RSI dose comes from

StatPearls gives 1 mg/kg for intubation, and the FDA label’s rapid sequence range is 0.6 to 1.2 mg/kg. So 1 mg/kg sits inside the labelled range, in its upper half. The label’s recommended initial dose for routine tracheal intubation, separate from the RSI statement, is 0.6 mg/kg. Its RSI figure is framed for “appropriately premedicated and adequately anesthetized patients,” and the label never mentions emergency-department or prehospital use. In the label’s Table 5, larger doses reach maximum block sooner and last longer.

What does 1 mg/kg of rocuronium come to for an 80 kg adult?

80 mg, as an arithmetic estimate. 80 kg x 1 mg/kg = 80 mg. A weight given in pounds converts first: the calculator divides by 2.2, so 176 lb becomes 80 kg before the multiplication runs. The medications card rounds the result to a whole milligram. Pounds to kilograms before the mg/kg math gets its own page.

Rocuronium dosing weight: actual body weight, and where obesity splits the sources

The label bases the obese-patient initial dose on actual body weight, and states rocuronium’s pharmacodynamics don’t differ between obese and nonobese patients dosed that way. Rapid Vent Calculator multiplies 1 mg/kg by the actual weight entered, and its medications card adds: “In obesity, some references use IBW or adjusted body weight for selected agents, especially nondepolarizing paralytics.” A 2021 review suggests ideal or adjusted (lean) weight for non-depolarizing paralytics as a class (Erstad and Barletta, 2021). In an ED study of obese adults, ideal-weight dosing wasn’t shown non-inferior to actual-weight dosing, and paralysis ran shorter under it, 43 minutes against 71 (McDowell et al., 2024). Both practices are in use, and this page ranks neither. Actual vs ideal body weight for every RSI drug lays out the full comparison.

When sources describe a higher rocuronium dose: 1.2 mg/kg and above

Two 2026 observational studies associate doses above 1.2 mg/kg with higher first-attempt success, and the label ties higher doses to a longer block. Each position carries its own citation, and this page adjudicates none of them.

The label’s RSI range tops out at 1.2 mg/kg, and it states that “higher doses of rocuronium bromide injection produce a longer duration of action.” In a secondary analysis of two multicenter trials of critically ill adults, doses above 1.2 mg/kg were associated with higher first-attempt success overall, adjusted relative risk 1.07 (95% CI 1.02 to 1.12). That difference held for ICU intubations, RR 1.13 (1.06 to 1.20), but not for ED intubations, RR 0.97 (0.89 to 1.04) (April et al., 2026); the authors call for a randomized trial given possible confounding. In a single-center retrospective study of ED and ICU intubations, doses above 1.2 mg/kg were associated with first-attempt success of 100% versus 89.5%, and fewer mean attempts. No other secondary outcome or subgroup, including obesity or hypoperfusion, differed (Szesnat et al., 2026).

These are associations, not a recommended dose. Which figure applies is set by the crew’s protocol and medical direction.

Rocuronium duration by dose: why it matters after the tube

At intubating doses rocuronium lasts from about half an hour to over an hour, depending on the dose. The induction agent given with it lasts minutes.

Rocuronium clinical duration by dose on the FDA labelA horizontal chart from 0 to 170 minutes. Adults 18 to 64: 0.45 mg/kg median 22 minutes, range 12 to 31; 0.6 mg/kg median 31 minutes, range 15 to 85; 0.9 mg/kg median 58 minutes, range 27 to 111; 1.2 mg/kg median 67 minutes, range 38 to 160. Adults 65 and older: 0.6 mg/kg median 46 minutes, range 22 to 73; 0.9 mg/kg median 62 minutes, range 49 to 75; 1.2 mg/kg median 94 minutes, range 64 to 138. A note between the 0.9 and 1.2 mg/kg adult rows states there is no label row at 1.0 mg/kg, the calculator’s figure. A reference band from 0 to 10 minutes marks induction agents by label: etomidate 3 to 5 minutes, ketamine 5 to 10 minutes.Shaded, 0 to 10 min: induction agents by FDA label, etomidate 3 to 5 min, ketamine 5 to 10 min0306090120150 minAdults 18 to 640.45 mg/kg: 22 min (12 to 31)0.6 mg/kg: 31 min (15 to 85)0.9 mg/kg: 58 min (27 to 111)No label row at 1.0 mg/kg, the calculator’s figure1.2 mg/kg: 67 min (38 to 160)Adults 65 and older0.6 mg/kg: 46 min (22 to 73)0.9 mg/kg: 62 min (49 to 75)1.2 mg/kg: 94 min (64 to 138)
Median and range of clinical duration (time to 25% recovery) under anesthesia, from the FDA rocuronium label; induction-agent durations from their FDA labels. Emergency conditions may differ. None of this is a dosing instruction.

Under opioid, nitrous oxide, and oxygen anesthesia, the label’s adults 18 to 64 show median clinical duration of 31 minutes at 0.6 mg/kg, 58 at 0.9 mg/kg, and 67 at 1.2 mg/kg. The label has no 1.0 mg/kg row, so the calculator’s dose sits between the 0.9 and 1.2 mg/kg figures, and this page does not interpolate one. By contrast, the FDA ketamine label gives 5 to 10 minutes of surgical anesthesia and the etomidate label 3 to 5 minutes, and StatPearls notes that most induction agents used for RSI have short half-lives. The relevant question here is how long this patient stays paralyzed after the sedative wears off, not which paralytic to choose in the first place. Rocuronium vs succinylcholine for RSI covers that choice.

How long does rocuronium last in older adults and liver disease?

Longer, per the label. In adults 65 and older, median clinical duration runs 46, 62, and 94 minutes at 0.6, 0.9, and 1.2 mg/kg, and older adults “may be at increased risk for residual neuromuscular block.” In hepatic disease, mean clinical duration is “about 1.5 times longer” than with normal function; in renal failure, the label reports “a greater variation in duration of effect.” None of this changes the app’s number, which doesn’t know age, liver function, or protocol.

Verify the calculated rocuronium RSI dose against the patient

Rapid Vent Calculator’s medications card lists rocuronium under “NEUROMUSCULAR BLOCKERS,” the 1 mg/kg scalar beside the calculated milligram result, computed from the actual weight entered. The footer beneath the doses reads: “Displayed doses are calculated from entered actual body weight.” The arithmetic doesn’t know the patient’s age, liver function, build, or protocol, doesn’t adjust for any of them, and doesn’t know how long the block will last. It multiplies the weight it’s given. Whether 1 mg/kg is the figure for this patient is the protocol’s and the clinician’s call.

After the rocuronium: sedation and the first vent settings

The label states rocuronium “has no known effect on consciousness, pain threshold, or cerebration” and that its administration “must be accompanied by adequate anesthesia or sedation.”

Is rocuronium a sedative or a paralytic?

A paralytic, a non-depolarizing neuromuscular blocking agent, with no known effect on consciousness. The patient’s stillness says nothing about awareness.

The ED-AWARENESS study found possible or definite awareness with paralysis in 2.6% of ventilated ED adults, and rocuronium exposure was associated with it (unadjusted odds ratio 5.1, 95% CI 1.30 to 20.1). Sedation after the tube is scored on a scale, not eyeballed (NASEMSO v3.0); RASS reads movement, and its validation excluded patients under neuromuscular blockade (Sessler et al., 2002), so a paralyzed patient can’t be scored on it until the block wears off. Scoring sedation on the RASS scale once the block wears off covers that scale, with no band or target here. Whether the induction agent or the paralytic goes first is its own question. For the ventilator, the weight switches: tidal volume runs on ideal body weight, not the actual weight the dose used (StatPearls NBK537072). The initial ventilator settings once the paralytic is on board pick up from there, and post-intubation management while rocuronium is still working carries it further.

Sources

  1. US Food and Drug Administration. Rocuronium bromide injection prescribing information (Hospira, Inc.). DailyMed; revised June 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=309aeb1b-8022-4df7-8194-ae6529e3395c
  2. Hendrix JM, Regunath H. Intubation Endotracheal Tube Medications. In: StatPearls. StatPearls Publishing; updated January 19, 2025. NCBI Bookshelf NBK459276. https://www.ncbi.nlm.nih.gov/books/NBK459276/
  3. April MD, Butler H, DeMasi SC, et al. Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. American Journal of Respiratory and Critical Care Medicine. 2026;212(8):1740-1749. https://pmc.ncbi.nlm.nih.gov/articles/PMC13424686/
  4. Szesnat M, Watts A, Tobin MA, Cason TH, Gibbs M. Rocuronium dosing for rapid sequence intubation: a retrospective analysis in ED and ICU settings. American Journal of Emergency Medicine. 2026;109:75-80. https://pubmed.ncbi.nlm.nih.gov/42385663/
  5. Erstad BL, Barletta JF. Dosing of neuromuscular blocking agents in patients with obesity: a narrative review. Anaesthesia and Intensive Care. 2021;49(2):98-104. https://pubmed.ncbi.nlm.nih.gov/33906465/
  6. McDowell M, Lewandowski A, Desai D, et al. Rocuronium dosing by ideal vs total body weight in obesity: a prospective, observational non-inferiority study. Western Journal of Emergency Medicine. 2024;25(1):22-27. https://pmc.ncbi.nlm.nih.gov/articles/PMC10777192/
  7. Pappal RD, Roberts BW, Mohr NM, et al. The ED-AWARENESS Study: A Prospective, Observational Cohort Study of Awareness With Paralysis in Mechanically Ventilated Patients Admitted From the Emergency Department. Annals of Emergency Medicine. 2021;77(5):532-544. https://pmc.ncbi.nlm.nih.gov/articles/PMC8166299/
  8. Kuhl EA, Perera TB. Prehospital Mechanical Ventilation. In: StatPearls. StatPearls Publishing; updated March 8, 2024. NCBI Bookshelf NBK537072. https://www.ncbi.nlm.nih.gov/books/NBK537072/
  9. US Food and Drug Administration. Ketamine Hydrochloride Injection, USP (CIII) prescribing information (Civica, Inc.). DailyMed; revised June 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58c86d9b-8694-4bd8-8254-f19ee3ad60b0
  10. US Food and Drug Administration. AMIDATE (etomidate) injection prescribing information (Hospira, Inc.). DailyMed; revised April 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7ed5bf8-ba75-44dc-8f81-96b4ad5766be
  11. NASEMSO Medical Directors Council. National Model EMS Clinical Guidelines, Version 3.0. National Association of State EMS Officials; March 2022.
  12. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. American Journal of Respiratory and Critical Care Medicine. 2002;166(10):1338-1344. https://pubmed.ncbi.nlm.nih.gov/12421743/